M&A Deal Summary

Alvogen Acquires Dream Pharma

On August 6, 2014, Alvogen acquired life science company Dream Pharma for 187M USD

Acquisition Highlights
  • This is Alvogen’s 4th transaction in the Life Science sector.
  • This is Alvogen’s largest (disclosed) transaction.
  • This is Alvogen’s 2nd transaction in South Korea.

M&A Deal Summary

Date 2014-08-06
Target Dream Pharma
Sector Life Science
Buyer(s) Alvogen
Deal Type Add-on Acquisition
Deal Value 187M USD

Target

Dream Pharma

Seoul, South Korea
Dream Pharma Corp. is a generic pharmaceutical company.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Alvogen

Pine Brook, New Jersey, United States

Category Company
Founded 2009
Sector Life Science
DESCRIPTION

Alvogen is a multinational pharmaceuticals company focused on developing, manufacturing, and distributing generic, brand, over-the-counter brands (OTC), and biosimilar products. Alvogen was founded in 2009 and is based in Pine Brook, New Jersey.


DEAL STATS #
Overall 4 of 8
Sector: Life Science M&A 4 of 8
Type: Add-on Acquisition M&A Deals 2 of 3
Country: South Korea M&A 2 of 2
Year: 2014 M&A 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-12-31 LaborMed Pharma

Ljubljana, Romania

LaborMed Pharma is a manufacturer and distributor generic pharmaceuticals primarily for cardiovascular and central nervous system aliments. The Company has also launched a portfolio of drugs for diabetes. LaborMed Pharma is based in Ljubljana, Romania.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-06 Bayer Pharma AG - Hormonal Branded Products

Russia

Bayer Pharma AG - Hormonal Branded Products - Klimonorm (Hormone replacement therapy), Progynova (Hormone replacement therapy), Triquilar ( Female contraception) and Microgynon (Female contraception) and Climene (Hormone replacement therapy).

Buy -